CREATING SHAREHOLDER VALUE

Biohaven is a broad portfolio biopharmaceutical development company, discovering and developing innovative late-stage product candidates targeting neurological and neuropsychiatric diseases, including rare disorders and strategic therapeutic adjacencies.
Latest Press Releases


Events


biohaven office
BIOHAVEN
EVENTS
biohaven office
CORPORATE
PRESENTATION
Vlad Coric, CEO
LETTER FROM THE
CHAIRMAN & CEO

VIDEOS

play video
Fastmoney

INTERVIEW WITH CEO VLAD CORIC M.D. ON CNBC’S FAST MONEY

play video
Madmoney video

Interview with CEO Vlad Coric M.D. on CNBC’s Mad Money

play video
Biohaven MOA video

Diseases related to glutamate dysregulation

x